These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 24022244)

  • 61. [Blood, blood components and plasma derivatives. Guideline-based implementation].
    Heim MU
    Med Klin Intensivmed Notfmed; 2011 Nov; 106(3):183-8. PubMed ID: 21997438
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The role of hospital transfusion committees in blood product conservation.
    Haynes SL; Torella F
    Transfus Med Rev; 2004 Apr; 18(2):93-104. PubMed ID: 15067589
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Therapy with blood products].
    Petros S
    Med Klin Intensivmed Notfmed; 2016 Apr; 111(3):241-9; quiz 250-1. PubMed ID: 26825633
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Rethinking blood components and patients: Patient blood management. Possible ways for development in France.
    Folléa G
    Presse Med; 2016; 45(7-8 Pt 2):e273-80. PubMed ID: 27476011
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Factors influencing the uptake of technologies to minimize perioperative allogeneic blood transfusion: an interview study of national and institutional stakeholders.
    Treloar CJ; Hewitson PJ; Henderson KM; Harris G; Henry DA; McGrath KM
    Intern Med J; 2001; 31(4):230-6. PubMed ID: 11456036
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Decision making in perioperative transfusion.
    Isbister JP
    Transfus Apher Sci; 2002 Aug; 27(1):19-28. PubMed ID: 12201467
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Audit of the use of packed red blood cells in association with seven common surgical procedures.
    Pinkerton PH; Coovadia AS; Seigel C
    Transfus Med; 1992 Sep; 2(3):231-4. PubMed ID: 1308834
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A successful experience of the Iranian blood transfusion organization in improving accessibility and affordability of plasma derived medicine.
    Chegini A; Torab SA; Pourfatollah AA
    Transfus Apher Sci; 2017 Feb; 56(1):12-16. PubMed ID: 28214180
    [TBL] [Abstract][Full Text] [Related]  

  • 69. AAGBI guidelines: the use of blood components and their alternatives 2016.
    Klein AA; Arnold P; Bingham RM; Brohi K; Clark R; Collis R; Gill R; McSporran W; Moor P; Rao Baikady R; Richards T; Shinde S; Stanworth S; Walsh TS
    Anaesthesia; 2016 Jul; 71(7):829-42. PubMed ID: 27062274
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Intra-operative transfusion management: the usefulness of point-of-care coagulation monitoring.
    Feltracco P; Serra E; Ori C
    Blood Transfus; 2012 Jul; 10(3):398-9; author reply 400-1. PubMed ID: 22337271
    [No Abstract]   [Full Text] [Related]  

  • 71. Dried plasma: state of the science and recent developments.
    Pusateri AE; Given MB; Schreiber MA; Spinella PC; Pati S; Kozar RA; Khan A; Dacorta JA; Kupferer KR; Prat N; Pidcoke HF; Macdonald VW; Malloy WW; Sailliol A; Cap AP
    Transfusion; 2016 Apr; 56 Suppl 2():S128-39. PubMed ID: 27100749
    [TBL] [Abstract][Full Text] [Related]  

  • 72. How do we forecast tomorrow's transfusion: Infectious safety?
    Dodd RY; Stramer SL
    Transfus Clin Biol; 2023 Feb; 30(1):35-38. PubMed ID: 35987477
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Optimizing current blood utilization practices in perioperative patients using the lean team approach.
    Rodrigues ES; Ramakrishna H
    Ann Card Anaesth; 2015; 18(4):464-6. PubMed ID: 26440229
    [No Abstract]   [Full Text] [Related]  

  • 74. [Transfusion management].
    Stefanova A
    Akush Ginekol (Sofiia); 2005; 44(3):31-5. PubMed ID: 16028389
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Transfusion-related immunomodulation and cancer.
    Goubran H; Sheridan D; Radosevic J; Burnouf T; Seghatchian J
    Transfus Apher Sci; 2017 Jun; 56(3):336-340. PubMed ID: 28606449
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Adverse effects of methods for minimizing perioperative allogeneic transfusion: a critical review of the literature.
    Faught C; Wells P; Fergusson D; Laupacis A
    Transfus Med Rev; 1998 Jul; 12(3):206-25. PubMed ID: 9673005
    [No Abstract]   [Full Text] [Related]  

  • 77. Shared surgery blood reserve reduces surgery suspension rate due to blood unavailability.
    Duarte da Silva EH; Cordeiro A; de Souza Saboia A; Soares de Souza TC; Azevedo Silva F
    Transfus Apher Sci; 2022 Apr; 61(2):103305. PubMed ID: 34772628
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Special considerations for the use of pathogen reduced blood components in pediatric patients: An overview.
    Goodrich RP; Segatchian J
    Transfus Apher Sci; 2018 Jun; 57(3):374-377. PubMed ID: 29773498
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Transfusion medicine in practice].
    Makino S
    Rinsho Ketsueki; 2016; 57(10):2232-2240. PubMed ID: 27795535
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Blood products for resuscitation: moving forward by going backward.
    Ness PM; Gehrie EA
    Transfusion; 2019 Feb; 59(S1):834-836. PubMed ID: 30737820
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.